Long-acting insulin analogs versus neutral protamine hagedorn insulin and the risk of severe hypoglycemia among patients in type 2 diabetes in the United Kingdom

被引：0
|
作者：
Brunetti, Vanessa C. [1 ]
Filion, Kristian [2 ]
Yu, Oriana Hoi Yun [2 ]
Platt, Robert [2 ]
机构：
[1] McGill, Dept Epidemiol Biostatist & Occupat Hlth, Montreal, PQ, Canada
[2] McGill Univ, Montreal, PQ, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
267
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [21] Replacement of neutral protamine Hagedorn insulin with the long-acting insulin analogue, detemir, improves glycemic control without weight gain in basal-bolus insulin therapy in Japanese patients with type 1 diabetes
    Hayakawa, Taro
    Ishii, Michiyo
    Watanabe, Megumi
    Iwase, Hiroya
    Nishimura, Asako
    Monden, Takako
    Kamiuchi, Kenji
    Isono, Motohide
    Shibata, Nobuhito
    JOURNAL OF DIABETES INVESTIGATION, 2011, 2 (01) : 71 - 77
  • [22] Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes
    Lipska, Kasia J.
    Parker, Melissa M.
    Moffet, Howard H.
    Huang, Elbert S.
    Karter, Andrew J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (01): : 53 - 62
  • [23] Twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn therapy for newly diagnosed type 1 diabetes - Reply
    Hassan, Krishna V.
    PEDIATRICS, 2008, 122 (03) : 676 - 676
  • [24] Comparison of Incidence of Acute Myocardial Infarction in Patients With Type 2 Diabetes Mellitus Following Initiation of Neutral Protamine Hagedorn Insulin Versus Insulin Glargine
    Rhoads, George G.
    Kosiborod, Mikhail
    Nesto, Richard W.
    Fonseca, Vivian A.
    Lu, Shou-En
    Zhang, Quanwu
    Foody, Joanne M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (07): : 910 - 916
  • [25] Effects of mealtime insulin aspart and bedtime neutral protamine Hagedorn insulin on postprandial coagulation and fibrinolysis in patients with type 2 diabetes
    Bladbjerg, E. M.
    Henriksen, J. E.
    Akram, S.
    Gram, J.
    DIABETES OBESITY & METABOLISM, 2012, 14 (05): : 447 - 453
  • [26] Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine Hagedorn insulin in patients with type 2 diabetes
    Linn, Thomas
    Fischer, Britta
    Soydan, Nedim
    Eckhard, Michael
    Ehl, Julia
    Kunz, Clemens
    Bretzel, Reinhard G.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10): : 3839 - 3846
  • [27] COMPARISON OF HYPOGLYCEMIA BETWEEN COMBINATION OF INSULIN DETEMIR AND ASPART WITH COMBINATION OF NPH (NEUTRAL PROTAMINE HAGEDORN) AND REGULAR INSULIN IN PATIENTS OF TYPE 1 DIABETES MELLITUS
    Hussain, Ibrar
    Ul Javed, Soud
    Abid, Ali Farhan
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (04): : 7488 - 7499
  • [28] Lower severe hypoglycemia risk: Insulin glargine versus NPH insulin in type 2 diabetes
    Dailey, George
    Strange, Poul
    AMERICAN JOURNAL OF MANAGED CARE, 2008, 14 (01): : 25 - 30
  • [29] Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus
    Horvath, K.
    Jeitler, K.
    Berghold, A.
    Ebrahim, S. H.
    Gratzer, T. W.
    Plank, J.
    Kaiser, T.
    Pieber, T. R.
    Siebenhofer, A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (02):
  • [30] COST-EFFECTIVENESS ANALYSIS OF INSULIN DETEMIR VERSUS INSULIN NEUTRAL PROTAMINE HAGEDORN (NPH) IN PATIENTS WITH TYPE 1 DIABETES MELLITUS IN SPAIN
    Ramirez de Arellano, A.
    Lizan, L.
    Prades, M.
    Morales, C.
    De Luis, D.
    VALUE IN HEALTH, 2014, 17 (07) : A343 - A343
12345